OTC Markets EXMKT - Delayed Quote USD

GB Sciences, Inc. (GBLX)

0.0002

0.0000

(0.00%)

At close: April 23 at 1:51:45 PM EDT

GB Sciences Signs Letter of Intent for a License to Develop and Market Their Cannabinoid-Based Parkinson’s Formulation With Endopure Life Sciences

GB Sciences' Licensing Deal with Endopure Life Sciences will also include Rights to Develop and Market GB Sciences' Cannabinoid-based Treatments for a Suite of Neurological Disorders LAS VEGAS, NV / ACCESSWIRE / July 2, 2024 / GB Sciences, Inc. (OTCQB:GBLX), ...

ACCESS Newswire 9 months ago

GBLX
0.00%

Performance Overview

Return	GBLX	S&P 500 (^GSPC)
YTD	-95.00%	-8.60%
1-Year	-96.88%	+6.02%
3-Year	-99.36%	+25.85%